CAMPHOR, MENTHOL, METHYL SALICYLATE

N/A

Manufactured by Hisamitsu America, Inc.

141 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CAMPHOR, MENTHOL, METHYL SALICYLATE

CAMPHOR, MENTHOL, METHYL SALICYLATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Hisamitsu America, Inc.. The most commonly reported adverse reactions for CAMPHOR, MENTHOL, METHYL SALICYLATE include APPLICATION SITE PAIN, APPLICATION SITE BURN, CHEMICAL INJURY, DRUG INEFFECTIVE, ERYTHEMA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CAMPHOR, MENTHOL, METHYL SALICYLATE.

Top Adverse Reactions

APPLICATION SITE PAIN6 reports
APPLICATION SITE BURN5 reports
CHEMICAL INJURY4 reports
DRUG INEFFECTIVE4 reports
ERYTHEMA3 reports
MALAISE3 reports
PAIN3 reports
RASH3 reports
ASTHENIA2 reports
BLISTER2 reports
BONE PAIN2 reports
BURNING SENSATION2 reports
CHEMICAL BURN2 reports
CHEST PAIN2 reports
DIZZINESS2 reports
DYSPNOEA2 reports
GAIT DISTURBANCE2 reports
INSOMNIA2 reports
NEOPLASM MALIGNANT2 reports
OFF LABEL USE2 reports
RASH PRURITIC2 reports
RENAL FAILURE2 reports
SKIN BURNING SENSATION2 reports
THERAPEUTIC RESPONSE UNEXPECTED2 reports
THERMAL BURN2 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS2 reports
ABDOMINAL PAIN1 reports
AMNESIA1 reports
ANAEMIA1 reports
ANGIOPLASTY1 reports
APPLICATION SITE ERYTHEMA1 reports
APPLICATION SITE IRRITATION1 reports
APPLICATION SITE PRURITUS1 reports
APPLICATION SITE REACTION1 reports
ASTHMA1 reports
BACTERIAL INFECTION1 reports
BLEPHAROSPASM1 reports
BLINDNESS UNILATERAL1 reports
BLOOD POTASSIUM INCREASED1 reports
BLOOD PRESSURE DECREASED1 reports
BLOOD PRESSURE INCREASED1 reports
BONE DISORDER1 reports
BRONCHOSPASM1 reports
BURNS SECOND DEGREE1 reports
CATARACT1 reports
CAUDA EQUINA SYNDROME1 reports
CAUSTIC INJURY1 reports
CELLULITIS1 reports
CEREBRAL INFARCTION1 reports
CHEMICAL BURN OF SKIN1 reports
CONDITION AGGRAVATED1 reports
CONSTIPATION1 reports
CROHN'S DISEASE1 reports
DECREASED APPETITE1 reports
DEEP VEIN THROMBOSIS1 reports
DEPRESSED MOOD1 reports
DERMATITIS ALLERGIC1 reports
DERMATITIS BULLOUS1 reports
DISABILITY1 reports
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION1 reports
DRUG INTERACTION1 reports
DRUG INTOLERANCE1 reports
DYSSTASIA1 reports
EATING DISORDER1 reports
EXPIRED DRUG ADMINISTERED1 reports
EYE PAIN1 reports
FACIAL PAIN1 reports
FEELING ABNORMAL1 reports
FIBROSIS1 reports
GLAUCOMA1 reports
HEAD INJURY1 reports
HERNIA1 reports
HYPERHIDROSIS1 reports
HYPERSENSITIVITY1 reports
HYPERTENSION1 reports
HYPOGONADISM1 reports
ILEUS1 reports
INADEQUATE ANALGESIA1 reports
INCORRECT STORAGE OF DRUG1 reports
JOINT SWELLING1 reports
MALNUTRITION1 reports
MENISCUS LESION1 reports
MIGRAINE1 reports
MOOD ALTERED1 reports
MUSCLE SPASMS1 reports
MUSCULAR WEAKNESS1 reports
MYALGIA1 reports
MYELOPATHY1 reports
NECK INJURY1 reports
NEPHRECTOMY1 reports
NERVE INJURY1 reports
NEURODEGENERATIVE DISORDER1 reports
NON CARDIAC CHEST PAIN1 reports
OEDEMA PERIPHERAL1 reports
OROMANDIBULAR DYSTONIA1 reports
ORTHOSTATIC HYPOTENSION1 reports
OSTEOPOROSIS1 reports
OVERDOSE1 reports
PAIN IN EXTREMITY1 reports
PAIN OF SKIN1 reports

Report Outcomes

Out of 48 classified reports for CAMPHOR, MENTHOL, METHYL SALICYLATE:

Serious 70.8%Non-Serious 29.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female30 (65.2%)
Male16 (34.8%)

Reports by Age

Age 202 reports
Age 362 reports
Age 372 reports
Age 632 reports
Age 652 reports
Age 752 reports
Age 291 reports
Age 321 reports
Age 351 reports
Age 411 reports
Age 421 reports
Age 441 reports
Age 481 reports
Age 491 reports
Age 511 reports
Age 521 reports
Age 531 reports
Age 561 reports
Age 571 reports
Age 581 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CAMPHOR, MENTHOL, METHYL SALICYLATE?

This profile reflects 141 FDA FAERS reports that mention CAMPHOR, MENTHOL, METHYL SALICYLATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CAMPHOR, MENTHOL, METHYL SALICYLATE?

Frequently reported terms in FAERS include APPLICATION SITE PAIN, APPLICATION SITE BURN, CHEMICAL INJURY, DRUG INEFFECTIVE, ERYTHEMA, MALAISE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CAMPHOR, MENTHOL, METHYL SALICYLATE?

Labeling and FAERS entries often list Hisamitsu America, Inc. in connection with CAMPHOR, MENTHOL, METHYL SALICYLATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.